Veracyte (VCYT) Cash from Investing Activities (2012 - 2026)
Veracyte (VCYT) posted quarterly Cash from Investing Activities of -$13.5 million for Q2 2026, down 5946.88% year-over-year from $231662.2 in Q2 2025, and up 89.41% on a QoQ basis from -$128.0 million in Q1 2026.
Veracyte (VCYT) Cash from Investing Activities (2012 - 2026) Analysis & Trends
Veracyte has reported Cash from Investing Activities for 15 years, with the latest figure at -$13.5 million in Q2 2026.
- Cash from Investing Activities for Q2 2026 came in at -$13.5 million, down 5946.88% year-over-year; the trailing twelve-month figure through Jun 2026 was -$98.7 million (up 8.99% YoY), and the FY2025 annual result was -$9.2 million, up 83.64% from the prior year.
- Cash from Investing Activities rose to -$13.5 million in Q2 2026, from -$128.0 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $48.3 million in Q3 2025 and troughed at -$128.0 million in Q1 2026.
- A 5-year average of -$12.3 million and a median of -$2.8 million in 2023 frame the typical range for Cash from Investing Activities.
- The widest annual swing landed in 2022, when Cash from Investing Activities slumped 6965.97%; it then surged 2252.68% in 2025.
- A 5-year view of Cash from Investing Activities shows it stood at -$26.4 million in 2022, then soared by 90.55% to -$2.5 million in 2023, then tumbled by 2068.24% to -$54.1 million in 2024, then jumped by 89.97% to -$5.4 million in 2025, then slumped by 149.45% to -$13.5 million in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$13.5 million in Q2 2026, -$128.0 million in Q1 2026, and -$5.4 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 164.00 Mn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -10.15 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | -25.50 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | -77.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -381.00 Mn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -32.14 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -122.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -1.94 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -134.00 Mn |
| 10 | Veracyte | 3.69 Bn | 3.39 Bn | 108.55 Mn | -13.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -13.55 Mn |
| Jun 30, 2026 | -13.55 Mn |
| Mar 31, 2026 | -127.96 Mn |
| Mar 31, 2026 | -127.96 Mn |
| Dec 31, 2025 | -5.43 Mn |
| Dec 31, 2025 | -5.43 Mn |
| Sep 30, 2025 | 48.26 Mn |
| Sep 30, 2025 | 48.26 Mn |
| Jun 30, 2025 | -224,000.00 |
| Jun 30, 2025 | -224,000.00 |
| Mar 31, 2025 | -51.82 Mn |
| Mar 31, 2025 | -51.82 Mn |
| Dec 31, 2024 | -54.14 Mn |
| Dec 31, 2024 | -54.14 Mn |
| Sep 30, 2024 | -2.24 Mn |
| Sep 30, 2024 | -2.24 Mn |
| Jun 30, 2024 | -2.77 Mn |
| Jun 30, 2024 | -2.77 Mn |
| Mar 31, 2024 | 2.88 Mn |
| Mar 31, 2024 | 2.88 Mn |